China Health Industries Holdings Inc
China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. The company operates through three segments: Humankind, HLJ Huimeijia, and Others. The company offers hemp derivative products, such as hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brighte… Read more
China Health Industries Holdings Inc (CHHE) - Total Assets
Latest total assets as of March 2024: $4.13 Million USD
Based on the latest financial reports, China Health Industries Holdings Inc (CHHE) holds total assets worth $4.13 Million USD as of March 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
China Health Industries Holdings Inc - Total Assets Trend (2006–2023)
This chart illustrates how China Health Industries Holdings Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
China Health Industries Holdings Inc - Asset Composition Analysis
Current Asset Composition (June 2023)
China Health Industries Holdings Inc's total assets of $4.13 Million consist of 90.9% current assets and 9.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.1% |
| Accounts Receivable | $1.92K | 0.0% |
| Inventory | $40.61K | 0.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $964.77K | 2.1% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2006–2023)
This chart illustrates how China Health Industries Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: China Health Industries Holdings Inc's current assets represent 90.9% of total assets in 2023, an increase from 33.2% in 2006.
- Cash Position: Cash and equivalents constituted 0.1% of total assets in 2023, down from 5.5% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 5.0% in 2006.
- Asset Diversification: The largest asset category is intangible assets at 2.1% of total assets.
China Health Industries Holdings Inc Competitors by Total Assets
Key competitors of China Health Industries Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
China Health Industries Holdings Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - China Health Industries Holdings Inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - China Health Industries Holdings Inc is currently not profitable relative to its asset base.
China Health Industries Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.04 | 6.68 | 4.48 |
| Quick Ratio | 0.04 | 6.62 | 4.38 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-6.28 Million | $ 37.41 Million | $ 29.83 Million |
China Health Industries Holdings Inc - Advanced Valuation Insights
This section examines the relationship between China Health Industries Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.50 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -11.2% |
| Total Assets | $45.08 Million |
| Market Capitalization | $6.55K USD |
Valuation Analysis
Below Book Valuation: The market values China Health Industries Holdings Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: China Health Industries Holdings Inc's assets decreased by 11.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for China Health Industries Holdings Inc (2006–2023)
The table below shows the annual total assets of China Health Industries Holdings Inc from 2006 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-06-30 | $45.08 Million | -11.16% |
| 2022-06-30 | $50.75 Million | -5.83% |
| 2021-06-30 | $53.89 Million | +11.72% |
| 2020-06-30 | $48.24 Million | +5.42% |
| 2019-06-30 | $45.75 Million | +6.57% |
| 2018-06-30 | $42.93 Million | +2.95% |
| 2017-06-30 | $41.70 Million | +3.54% |
| 2016-06-30 | $40.28 Million | -2.96% |
| 2015-06-30 | $41.51 Million | +1.55% |
| 2014-06-30 | $40.87 Million | -24.92% |
| 2013-06-30 | $54.44 Million | +1.80% |
| 2012-06-30 | $53.48 Million | +26.18% |
| 2011-06-30 | $42.38 Million | +89.52% |
| 2010-06-30 | $22.36 Million | +136.19% |
| 2009-06-30 | $9.47 Million | +1245.65% |
| 2007-06-30 | $703.61K | -14.29% |
| 2006-06-30 | $820.88K | -- |